High profits may incentivize using anti-VEGF therapy over surgery for diabetic retinopathy
- Posted on: Jan 12 2023
- Leave a response
Greater financial rewards associated with intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy over pars plana vitrectomy may lead to bias in choosing the most appropriate treatment.
Source: AAO
Posted in: Uncategorized
